Profiling individuals living with hypertension in Saudi Arabia 2021: a nationwide descriptive study
Frontiers in Cardiovascular Medicine · 02.01.2026 · 12
DOI: 10.3389/fcvm.2025.1579109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 02.01.2026. Verfasst von Mohammed Senitan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, College of Health Sciences, Saudi Electronic University, Riyadh, Saudi Arabia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hypertension is a major global health challenge affecting 1.3 billion adults, increasing risks of cardiovascular diseases, strokes, and kidney failure. Using data from a nationally representative surveillance system in Saudi Arabia, this study profiles adults living with treated or aware hypertension vs. the rest of the population and examines co-occurring sociodemographic, behavioral, and clinical factors in 2021.
Methods
We analyzed data from the 2021 Sharik Health Indicators Surveillance System (SHISS), a nationwide cross-sectional phone survey employing proportional quota sampling across all 13 regions ( n = 14,007; response rate = 68.3%). Hypertension status was defined as self-reported physician diagnosis with current treatment; blood pressure was not directly measured, and the survey relied entirely on self-report. Weighted descriptive statistics summarized prevalence, and multivariable logistic regression estimated adjusted odds ratios (AORs, 95% CIs) for factors associated with hypertension. The mean participant age was 36.7 ± 13.7 years.
Results
Overall, 12.3% of respondents reported treated/aware hypertension. Among these, common comorbidities included hypercholesterolemia (47.9%), diabetes (42.8%), overweight/obesity (75.2%), heart disease (20.2%), and elevated depression risk (23.8%). In adjusted models, higher age (AOR 1.06 per year, 95% CI 1.05–1.06), education below bachelor's (AOR 1.31, 1.14–1.50), smoking (daily AOR 1.23, 1.03–1.48; occasional AOR 1.64, 1.28–2.08), overweight (AOR 1.93, 1.20–3.11), and obesity (AOR 2.53, 1.57–4.08) were significantly associated with hypertension. Strong associations were also observed with hypercholesterolemia (AOR 4.09, 3.56–4.71), heart disease (AOR 3.54, 2.84–4.42), and diabetes (AOR 2.64, 2.28–3.05).
Conclusions
Adults aware of and treated for hypertension in Saudi Arabia exhibit a high burden of behavioral risks and multimorbidity. These findings can guide targeted primary care screening, integrated chronic disease management, and population-level risk reduction programs (e.g., smoking cessation, weight control), with priority to older adults, individuals with lower educational attainment, and those with co-existing diabetes or dyslipidemia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health, College of Health Sciences, Saudi Electronic University, Riyadh, Saudi Arabia.
- Informed Decision-Making for Research and Studies, Riyadh, Saudi Arabia.
- Sharik Association for Research and Studies, Riyadh, Saudi Arabia.
- Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Zitieren
APA
Senitan, M., Althumiri, N. A., Alkhamaali, Z., Shaman, A. M., & BinDhim, N. F. (2026). Profiling individuals living with hypertension in Saudi Arabia 2021: a nationwide descriptive study. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1579109
Vancouver
Senitan M, Althumiri NA, Alkhamaali Z, Shaman AM, BinDhim NF. Profiling individuals living with hypertension in Saudi Arabia 2021: a nationwide descriptive study. Frontiers in Cardiovascular Medicine. 2026;12. doi:10.3389/fcvm.2025.1579109
BibTeX
@article{Senitan2026,
author = {Senitan, Mohammed and Althumiri, Nora A and Alkhamaali, Zaied and Shaman, Ahmed M and BinDhim, Nasser F},
title = {Profiling individuals living with hypertension in Saudi Arabia 2021: a nationwide descriptive study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {12},
doi = {10.3389/fcvm.2025.1579109}
}
EUVIMED